Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
June 18th 2014Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Read More